Investigating the effect of Inofolic in women with PCOS
Phase 3
- Conditions
- polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT20171208037790N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
age between 18 and 40
suffering from polycystic ovary syndrome
candidate for IVF treatment
Exclusion Criteria
concomitant metabolic disease like diabetes
allergy to myoinositol
morbid obesity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expression of genes related to oocyte quality in follicular fluid. Timepoint: Measurement is performed immediately after ovulation stimulation and puncture. Method of measurement: Polymerase chain reaction.
- Secondary Outcome Measures
Name Time Method Oxidative stress parameters in follicular fluid. Timepoint: Measurement is performed immediately after ovulation stimulation and puncture. Method of measurement: Reactive Oxygen Species (ROS) Assay Kit & Total Antioxidant Capacity(TAC) Assay Kit.